Titre : | Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness |
Revue : | Neuropsychiatric disease and treatment, 14 |
Auteurs : | Omori Y, Auteur ; Kanbayashi T ; Imanishi A ; Tsutsui K ; Sagawa Y ; Kikuchi YS ; Takeshima M ; Yoshizawa K ; Uemura S ; Shimizu T |
Type de document : | Article |
Editeur : | New Zealand, 2018 |
Pages : | p 451 |
Note générale : |
Erratum in:
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]. [Neuropsychiatr Dis Treat. 2018] = Corrigendum published online May 22, 2018: "This corrects the article "Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness" on page 451. On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”." |
Langues: | Anglais |
Mots-clés : | dystrophie myotonique de type 1 ; étude comparative ; étude rétrospective ; Japon ; liquide céphalorachidien ; orexin ; polysomnographie ; somnolence diurne ; trouble du sommeil |
Mots-clés: | muscleblind-like protein;myotonic dystrophy type 1;narcolepsy;orexin;sleep-onset rapid eye movement periods; |
Pubmed / DOI : | DOI : 10.2147/NDT.S158651 / Pubmed : 29445282 |
N° Profil MNM : | 2018022 |
En ligne : | http://www.ncbi.nlm.nih.gov/pubmed/29445282 |